Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

2.5K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
2.5K
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

2.0K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.0K
Gene Therapy00:59

Gene Therapy

27.7K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
27.7K
Overview of Advanced Functional Groups02:22

Overview of Advanced Functional Groups

30.4K

Functional groups are groups of atoms with specific chemical properties that occur within organic molecules and are sometimes denoted as “R”. Functional groups can “functionalize” a compound by enabling it to adopt different physical and chemical properties.
Types of Advanced Functional Groups
The table below summarizes some of the major functional groups in organic chemistry.
30.4K
Extraction: Advanced Methods00:56

Extraction: Advanced Methods

1.2K
Metal ions can be separated from one another by complexation with organic ligands–the chelating agent– to form uncharged chelates. Here, the chelating agent must contain hydrophobic groups and behave as a weak acid, losing a proton to bind with the metal. Since most organic ligands used in this process are insoluble or undergo oxidation in the aqueous phase, the chelating agent is initially added to the organic phase and extracted into the aqueous phase. The metal-ligand complex is...
1.2K
Group Therapy01:26

Group Therapy

472
Group therapy is a sociocultural approach to psychological treatment, where individuals with shared psychological challenges come together under the guidance of a mental health professional. This therapeutic modality offers unique opportunities for individuals to connect, share, and grow within the context of a supportive group. By fostering mutual understanding and collaboration, group therapy can address a range of psychological concerns effectively, often complementing or surpassing the...
472

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[From Bite to Loss of Vision-Ocular Complications of West Nile Virus].

Die Ophthalmologie·2026
Same author

Translating Cancer Genetics Care: Digital Tools to Improve Cancer Genetics Risk Assessment for Patients With Limited English Proficiency.

JCO oncology practice·2026
Same author

[Plasma proteomics in age-related macular degeneration].

Die Ophthalmologie·2026
Same author

A Dynamic Foraging Habitat Distribution Estimate for Green Turtles in the Great Barrier Reef.

Ecology and evolution·2026
Same author

Assessing the effectiveness of the one paleopathology workshop.

Evolution, medicine, and public health·2026
Same author

Adult lifespan normative data (18-92 years) for executive function tests; the Stroop colour word test, COWAT and Hayling sentence completion test.

Journal of neuropsychology·2025

Related Experiment Video

Updated: Feb 15, 2026

Assessment of the Anticoagulant and Anti-inflammatory Properties of Endothelial Cells Using 3D Cell Culture and Non-anticoagulated Whole Blood
07:08

Assessment of the Anticoagulant and Anti-inflammatory Properties of Endothelial Cells Using 3D Cell Culture and Non-anticoagulated Whole Blood

Published on: September 5, 2017

8.9K

Advances in anticoagulation therapy.

Emily Webster1, Michael Gil

  • 1Emily Webster practices at Boston Medical Center and is an instructor of emergency medicine at Boston University School of Medicine. Michael Gil practices at Emergency Physicians of Tidewater in Virginia Beach, Va., and is the director of education and training. The authors have disclosed no potential conflicts of interest, financial or otherwise.

JAAPA : Official Journal of the American Academy of Physician Assistants
|January 26, 2018
PubMed
Summary

Patients with atrial fibrillation (AF) often require anticoagulation to prevent thrombotic events. Novel oral anticoagulants provide new options, but treatment decisions must be individualized based on safety, efficacy, and cost.

More Related Videos

Immunometabolic Circuits in Infection for Advancing Host Directed Therapies
11:12

Immunometabolic Circuits in Infection for Advancing Host Directed Therapies

Published on: September 13, 2024

973
Cortical Neurogenesis: Transitioning from Advances in the Laboratory to Cell-Based Therapies
12:38

Cortical Neurogenesis: Transitioning from Advances in the Laboratory to Cell-Based Therapies

Published on: July 19, 2007

6.6K

Related Experiment Videos

Last Updated: Feb 15, 2026

Assessment of the Anticoagulant and Anti-inflammatory Properties of Endothelial Cells Using 3D Cell Culture and Non-anticoagulated Whole Blood
07:08

Assessment of the Anticoagulant and Anti-inflammatory Properties of Endothelial Cells Using 3D Cell Culture and Non-anticoagulated Whole Blood

Published on: September 5, 2017

8.9K
Immunometabolic Circuits in Infection for Advancing Host Directed Therapies
11:12

Immunometabolic Circuits in Infection for Advancing Host Directed Therapies

Published on: September 13, 2024

973
Cortical Neurogenesis: Transitioning from Advances in the Laboratory to Cell-Based Therapies
12:38

Cortical Neurogenesis: Transitioning from Advances in the Laboratory to Cell-Based Therapies

Published on: July 19, 2007

6.6K

Area of Science:

  • Cardiology
  • Pharmacology
  • Thrombosis Management

Background:

  • Atrial fibrillation (AF) is a significant risk factor for thrombotic diseases.
  • Anticoagulation is a cornerstone in managing AF for primary and secondary prevention of thromboembolic events.
  • Warfarin has been the traditional anticoagulant, but novel oral anticoagulants (NOACs) have emerged.

Purpose of the Study:

  • To review the role of anticoagulation in atrial fibrillation.
  • To discuss the emergence and implications of novel oral anticoagulants.
  • To highlight key factors in individualized treatment decision-making for AF patients.

Main Methods:

  • Literature review of anticoagulation strategies in AF.
  • Comparative analysis of warfarin and novel oral anticoagulants.
  • Discussion of clinical decision-making parameters.

Main Results:

  • Novel oral anticoagulants offer alternatives to warfarin for AF management.
  • Decision-making involves a multifactorial approach.

Conclusions:

  • Individualized patient management is crucial when selecting anticoagulation therapy for atrial fibrillation.
  • Key considerations include safety, tolerability, efficacy, cost, and ease of use for optimal patient outcomes.